Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?

Author： Nabholtz J-M.   Tonkin K.   Smylie M.   Au H-J.   Lindsay M-A.   Mackey J.  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.2, 2000-01, pp. : 187-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of taxanes in the treatment of breast cancer

By Nabholtz Jean-Marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1073-1094

Informa Healthcare

Access to resources Recommend Favorite

Taxanes in the Adjuvant Treatment of Breast Cancer

By Trauth Donna   Goldstein Lori J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 222-231

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Risks and Benefits of Taxanes in Breast and Ovarian Cancer

By Michaud L.B.  

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 401-428

Adis International

Access to resources Recommend Favorite

Costs of taxanes, capecitabine, quantified for breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Molecular Chemotherapy for Breast Cancer

By Patterson A.  

Drugs & Aging, Vol. 14, Iss. 2, 1999-02 ,pp. : 75-90

Adis International

Access to resources Recommend Favorite